MiR-328-3p reduced SLC7A5 3′UTR luciferase reporter activities and protein outcomes but did not alter the overall homeostasis of AAs. Combination treatment with miR-328 plus cisplatin or doxorubicin synergistically inhibited osteosarcoma cell proliferation. Here, SLC7A5 is linked to osteosarcoma.